IL3 and neoplasm: On the other hand, the release of inflammatory mediators, such IL-1, IL-3 and IL-6 by cancer cells, triggers the differentiation of megakaryocytes into platelets (57), thus fueling a vicious cycle where platelets and tumor cells continuously stimulate each-other’s growth.